hsa-mir-95: Hsa-mir-95 is a microRNA (miRNA) that has been identified as differentially expressed in various tissue types and disease states, indicating its potential role in cellular processes and disease pathogenesis [PMC9987318]. It is one of the miRNAs that exhibited considerable differential expression in both periapical and pulp tissues, suggesting its involvement in oral health or disease [PMC9987318]. Furthermore, hsa-mir-95 has been associated with type 2 diabetes mellitus (T2DM) through its target genes, highlighting a possible link with metabolic disorders [PMC10126023]. In the context of diabetic nephropathy (DN), hsa-mir-95 was among the miRNAs differentially expressed in kidney tissues when comparing healthy individuals to DN patients [PMC8616647]. Additionally, it was differentially expressed when comparing pancreatic neuroendocrine tumors (PNETs) to pancreatic ductal adenocarcinomas (PDACs), suggesting a role in pancreatic cancer biology [PMC7352720]. The potential of hsa-mir-95-containing extracellular vesicles (EVs) for regenerative medicine has also been noted due to their association with cellular proliferation and apoptosis inhibition [PMC10126023]. However, it was also identified as one of the miRNAs not previously detected as differentially expressed during control myogenesis, indicating a unique expression pattern under certain physiological conditions [PMC4186784].